Intervention

olmesartan medoxomil + hydrochlorothiazide, if necessary

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown2

Clinical trials

3 shown

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II HypertensionNCT00430638 · 2006-12-01

Isolated Systolic Hypertension in the Elderly and Very ElderlyNCT00751829 · 2003-07-01

Olmesartan Medoxomil Versus Losartan in Elderly and Very ElderlyNCT00751751 · 2003-06-01

Common conditions

Essential Hypertension1 Hypertension1 Isolated Systolic Hypertension1

Leading sponsors

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2 Daiichi Sankyo1

Trial status mix

COMPLETED3

Phase mix

PHASE32

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.